Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. VTGN
VTGN logo

VTGN

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

VTGN News

Vistagen Lawsuit Reminder for Investors

Mar 16 2026PRnewswire

Vistagen Lawsuit Reminder for Investors

Mar 14 2026Globenewswire

Vistagen Lawsuit Reminder for Investors

Mar 13 2026Globenewswire

Vistagen Faces Shareholder Class Action Lawsuit

Mar 12 2026Globenewswire

Investigation Launched into Vistagen Securities Litigation

Mar 12 2026Globenewswire

Vistagen Faces Class Action Lawsuit; Investors Urged to Act

Mar 11 2026Globenewswire

Vistagen Lawsuit Reminder for Investors

Mar 10 2026Globenewswire

Vistagen Faces Class Action Lawsuit Amid 80% Stock Plunge

Mar 10 2026Globenewswire

Vistagen Therapeutics Shareholder Notice Issued

Mar 10 2026PRnewswire

Vistagen Lawsuit Reminder for Investors

Mar 07 2026Globenewswire

Helus Pharma's HLP004 Phase 2 Study Results Disappoint

Mar 05 2026Benzinga

Vistagen Therapeutics Faces Class Action Lawsuit

Mar 05 2026Globenewswire

Vistagen Therapeutics Class Action Notice

Mar 05 2026PRnewswire

Notice of Class Action Lawsuit Against Vistagen Therapeutics

Mar 05 2026Globenewswire

Class Action Filed Against Vistagen for Investor Losses

Mar 05 2026Globenewswire

Vistagen Investors Urged to Discuss Legal Rights Amid Significant Losses

Mar 04 2026PRnewswire